CORZ
The table below shows Core Scientific, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M | $60.32M |
| Cost of revenue | $281.12M | $389.60M | $378.94M | $631.91M | $305.62M | $50.93M |
| Gross profit | $37.90M | $121.07M | $123.46M | $8.40M | $238.86M | $9.39M |
| R&D | - | $11.83M | $7.18M | $26.96M | $7.67M | $5.27M |
Core Scientific, Inc. reported annual revenue of $319.02M for fiscal year 2025. That is down 37.5% from $510.67M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $60.32M (FY 2020) to $319.02M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $159.22M |
| $113.69M |
| $108.11M |
| $213.28M |
| $60.49M |
| $14.55M |
| Operating income | -$245.59M | -$142.06M | $8.96M | -$2.11B | $131.49M | -$6.33M |
| Income tax | $583.00K | $859.00K | $683.00K | -$17.09M | $15.76M | $0.00 |
| Net income | -$288.62M | -$1.44B | -$246.49M | -$2.15B | $47.31M | -$12.21M |
| EPS (diluted) | -$0.88 | -$4.87 | -$0.65 | -$6.30 | $0.20 | -$0.14 |